Diabetes & Metabolism Journal (Sep 2024)

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients ( 2024;48:253-64)

  • Eun Young Lee

DOI
https://doi.org/10.4093/dmj.2024.0417
Journal volume & issue
Vol. 48, no. 5
pp. 1005 – 1007

Abstract

Read online

No abstracts available.